首頁 > 市場調查報告書 > 醫療設備

心血管設備

人工心臟瓣膜市場規模、佔有率和成長分析：按產品類型、應用、最終用戶和地區分類 - 產業預測，2026-2033年

市場調查報告書

商品編碼

2048567

人工心臟瓣膜市場規模、佔有率和成長分析：按產品類型、應用、最終用戶和地區分類 - 產業預測，2026-2033年

Prosthetic Heart Valves Market Size, Share, and Growth Analysis, By Product Type, By Application, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2026年05月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球人工心臟瓣膜市場價值為 48.2 億美元，預計到 2025 年將成長至 51.3 億美元，到 2033 年將成長至 85.2 億美元，在預測期（2026-2033 年）內複合年成長率為 6.52%。

人工心臟瓣膜市場正經歷顯著成長，這主要得益於瓣膜性心臟病盛行率的上升以及心血管治療方法的進步。該市場涵蓋機械瓣膜、生物瓣膜和經導管瓣膜，旨在改善心臟瓣膜功能障礙引起的血流動力學問題。由於製造能力的提升，經導管主動脈瓣置換術（TAVR）等微創治療方法在各個地區，尤其是在歐洲和北美，正蓬勃發展。隨著技術的進步，創新成為推動市場發展的主要動力，它不僅最大限度地降低了手術風險，還擴大了適用人群。更小巧、更可靠的瓣膜的出現，大大增加了在專業醫療機構進行的手術數量，滿足了中低風險患者的需求，並吸引了更多投資進入這一專業醫療領域。

全球人工心臟瓣膜市場促進因素

全球人工心臟瓣膜市場的主要促進因素之一是心血管疾病的盛行率上升，這推動了對先進心臟瓣膜置換解決方案的需求。隨著生活方式日益久坐不動和不健康，心臟瓣膜疾病和其他心臟相關疾病的發生率不斷上升，導致需要手術治療的患者人數不斷增加。此外，除了醫療技術的不斷進步外，人們對微創手術的認知和接受度不斷提高，也促進了對人工心臟瓣膜的需求。這是因為與傳統手術方法相比，人工心臟瓣膜能夠改善患者預後並縮短復原時間。

全球人工心臟瓣膜市場的限制因素

全球人工心臟瓣膜市場的主要限制因素是這些先進醫療設備的高昂成本以及植入手術所需的複雜流程。這種經濟負擔會限制病患的就醫機會，尤其是在醫療預算有限的發展中地區。此外，保險覆蓋範圍的不一致性以及報銷問題也會阻礙患者和醫療服務提供者選擇這些治療方法。手術的複雜性、潛在的併發症以及持續的患者管理和後續觀察需求，進一步加劇了人們對人工心臟瓣膜的猶豫，從而阻礙了市場成長。

全球人工心臟瓣膜市場趨勢

全球人工心臟瓣膜市場正經歷著向經導管介入治療的顯著轉變，這不僅擴大了符合植入條件的患者群體，也使治療重點從傳統的外科手術轉向了基於導管的瓣膜植入。這項轉變的驅動力在於醫療設備製造商和醫療機構之間的合作，雙方致力於改善管理機制、簡化圍手術全期流程，並為醫護人員提供全面的培訓。隨著手術流程的簡化，住院時間得以縮短，病患體驗也得到改善；同時，創新的轉診系統和服務模式也應運而生，為產業內的成長機會和策略夥伴關係鋪平了道路。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Edwards Lifesciences（Sapien TAVR）
Medtronic plc（CoreValve）
Abbott Laboratories（Tendyne）
Boston Scientific（Lotus）
LivaNova plc
On-X Life Technologies
Jenavalve Technology
TTK Healthcare
Cryolife Inc.
NVT AG
Colibri Heart Valve
Strait Access Technologies
Venus Medtech
Anteris Technologies
HLT Inc.

結論與建議

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Edwards Lifesciences（Sapien TAVR）
Medtronic plc（CoreValve）
Abbott Laboratories（Tendyne）
Boston Scientific（Lotus）
LivaNova plc
On-X Life Technologies
Jenavalve Technology
TTK Healthcare
Cryolife Inc.
NVT AG
Colibri Heart Valve
Strait Access Technologies
Venus Medtech
Anteris Technologies
HLT Inc.

結論與建議

簡介目錄

Product Code: SQMIG35A3420

Global Prosthetic Heart Valves Market size was valued at USD 4.82 Billion in 2024 and is poised to grow from USD 5.13 Billion in 2025 to USD 8.52 Billion by 2033, growing at a CAGR of 6.52% during the forecast period (2026-2033).

The prosthetic heart valves market is experiencing significant growth, fueled by the rising prevalence of valvular heart disease and advancements in cardiovascular treatment methods. This market encompasses mechanical, tissue, and transcatheter valves designed to rectify hemodynamic issues caused by malfunctioning heart valves. The shift towards less invasive procedures, such as transcatheter aortic valve replacement (TAVR), has gained traction in various regions, notably Europe and North America, thanks to enhanced production capabilities. Innovation is a key driver, as technologies evolve to minimize procedural risks and expand the patient demographic eligible for interventions. The emergence of smaller, more dependable valves has dramatically increased procedure volumes in specialized centers, addressing the needs of both intermediate and low-risk patient populations and attracting further investments in this specialized medical sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Prosthetic Heart Valves market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Prosthetic Heart Valves Market Segments Analysis

Global prosthetic heart valves market is segmented by product type, application, end-user and region. Based on product type, the market is segmented into Mechanical Heart Valves, Biological/Bioprosthetic Valves and TAVR Valves. Based on application, the market is segmented into Aortic Valve Replacement, Mitral Valve Replacement, Pulmonary Valve Replacement and Tricuspid Valve Replacement. Based on end-user, the market is segmented into Hospitals and Cardiac Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Prosthetic Heart Valves Market

A key market driver for the Global Prosthetic Heart Valves Market is the rising prevalence of cardiovascular diseases, which has heightened the demand for advanced heart valve replacement solutions. As lifestyles become increasingly sedentary and unhealthy, conditions such as heart valve disorders and other cardiac-related issues are on the rise, leading to a growing patient population requiring surgical interventions. Furthermore, continuous advancements in medical technology, along with increasing awareness and acceptance of minimally invasive procedures, boost the demand for prosthetic heart valves, as they offer improved patient outcomes and enhanced recovery times compared to traditional surgical options.

Restraints in the Global Prosthetic Heart Valves Market

A significant market restraint for the global prosthetic heart valves market is the high cost associated with these advanced medical devices and the surgical procedures required for their implantation. This financial burden can limit accessibility for patients, particularly in developing regions with constrained healthcare budgets. Additionally, insurance coverage discrepancies and reimbursement challenges can discourage both patients and healthcare providers from opting for these therapies. The complexity of the surgical procedures, coupled with potential complications and the need for ongoing patient management and follow-ups, further contributes to hesitancy in adopting prosthetic heart valves, thereby hindering market growth.

Market Trends of the Global Prosthetic Heart Valves Market

The Global Prosthetic Heart Valves market is experiencing a significant trend towards transcatheter expansion and access, facilitating broader eligibility for patients and shifting focus from traditional surgical interventions to catheter-based prosthesis implantation. This transformation is driven by collaborative efforts among medical device manufacturers and healthcare facilities to enhance delivery mechanisms, streamline perioperative processes, and provide comprehensive training for healthcare providers. As procedures become more simplified, resulting in reduced hospital stays and an improved patient experience, innovative referral practices and service options are emerging, paving the way for growth opportunities and strategic partnerships within the industry.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Prosthetic Heart Valves Market Size by Product Type & CAGR (2026-2033)

Market Overview
Mechanical Heart Valves
Biological/Bioprosthetic Valves
- Porcine
- Bovine Pericardial
TAVR Valves

Global Prosthetic Heart Valves Market Size by Application & CAGR (2026-2033)

Market Overview
Aortic Valve Replacement
Mitral Valve Replacement
Pulmonary Valve Replacement
Tricuspid Valve Replacement

Global Prosthetic Heart Valves Market Size by End-User & CAGR (2026-2033)

Market Overview
Hospitals
Cardiac Centers

Global Prosthetic Heart Valves Market Size & CAGR (2026-2033)

North America (Product Type, Application, End-User)
- US
- Canada
Europe (Product Type, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, End-User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Edwards Lifesciences (Sapien TAVR)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (CoreValve)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (Tendyne)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific (Lotus)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
On-X Life Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jenavalve Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TTK Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cryolife Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NVT AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Colibri Heart Valve
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Strait Access Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Venus Medtech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anteris Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HLT Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments